Ibandronate (as sodium) 3mg/3mL; soln for IV inj. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone ...

WASHINGTON, June 7 (Reuters) - Patients who want an injectable form of Roche Holding AG's bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not ...

Nutley, NJ - An injectable form of ibandronate (Boniva, Roche/GlaxoSmithKline) that can be given once every three months has been approved by the US Food and Drug Administration (FDA) for treatment of ...

Oct. 8, 2003 — Intermittent ibandronate for prevention of osteoporosis is effective and well tolerated, according to the results of a study published in the October issue of the Annals of Rheumatic ...

Roche announced the results from the first year of a phase III study (DIVA) investigating an intravenous injection of Bonviva/Boniva (ibandronate) with extended intervals between dosages, for the ...

While drug shortages often are tied to manufacturing interruptions, Roche's ($RHHBY) injectable form of its osteoporosis drug Boniva will be in limited supply for ...

Many companies have been caught off-guard by the extent to which generic competition has eaten away at their sales. Genentech says it managed to be caught off-guard by a lack of it, leading to a ...

Ibandronate (as sodium) 3mg/3mL; soln for IV inj. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone ...

WASHINGTON (Reuters) – Patients who want an injectable form of Roche Holding AG’s bone-strengthening drug Boniva may not be able to get it in the next few weeks because the company did not accurately ...

Unlike Boniva tablets, which people take once a month, Boniva injections are given once every three months. The U.S. Food and Drug Administration announced the shortage of Boniva vials on its website ...